Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome

Jong Moo Park, Kyusik Kang, Yong Jin Cho, Keun Sik Hong, Kyung Bok Lee, Tai Hwan Park, Soo Joo Lee, Youngchai Ko, Moon Ku Han, Jun Lee, Jae Kwan Cha, Dae Hyun Kim, Dong Eog Kim, Joon Tae Kim, Jay Chol Choi, Kyung Ho Yu, Byung Chul Lee, Ji Sung Lee, Juneyoung Lee, Philip B. GorelickHee Joon Bae

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective The effect of prestroke aspirin use on initial severity, hemorrhagic transformation, and functional outcome of ischemic stroke is uncertain. Methods Using a multicenter stroke registry database, patients with acute ischemic stroke of three subtypes (large artery atherosclerosis [LAA], small vessel occlusion [SVO], or cardioembolism [CE]) were identified. NIH stroke scale (NIHSS) and hemorrhagic transformation at presentation and discharge modified Rankin Scale (mRS) were compared between prestroke aspirin users and nonusers. Results Among the 10,433 patients, 1,914 (18.3%) reported prestroke aspirin use. On crude analysis, initial NIHSS scores of aspirin users were higher than nonusers (mean difference: 0.35; 95% confidence interval [CI]: 0.04-0.66). However, a multivariable analysis with an application of inverse probability of treatment weighting based on a propensity score of prestroke aspirin, having an interaction effect of prestroke aspirin use and stroke subtype in the model, showed less stroke severity for aspirin users in LAA, but not in SVO and CE than for nonusers; mean difference in NIHSS scores in LAA was -0.97 (95% CI: -1.45 to -0.49). With respect to hemorrhagic transformation and mRS, no significant interaction effects were found. Prestroke aspirin use increased the risk of hemorrhagic transformation (adjusted odd ratio: 1.34; 95% CI: 1.05-1.73), but decreased the odds of the higher discharge mRS (0.86; 0.76-0.96). Interpretation Prestroke aspirin use may reduce initial stroke severity in atherothrombotic stroke and can improve functional outcome at discharge despite an increase of hemorrhagic transformation irrespective of stroke subtype.

Original languageEnglish
Pages (from-to)560-568
Number of pages9
JournalAnnals of Neurology
Volume79
Issue number4
DOIs
Publication statusPublished - 2016 Apr 1

Fingerprint

Aspirin
Stroke
Atherosclerosis
Arteries
Confidence Intervals
Propensity Score
Registries
Odds Ratio
Databases

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Park, J. M., Kang, K., Cho, Y. J., Hong, K. S., Lee, K. B., Park, T. H., ... Bae, H. J. (2016). Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome. Annals of Neurology, 79(4), 560-568. https://doi.org/10.1002/ana.24602

Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome. / Park, Jong Moo; Kang, Kyusik; Cho, Yong Jin; Hong, Keun Sik; Lee, Kyung Bok; Park, Tai Hwan; Lee, Soo Joo; Ko, Youngchai; Han, Moon Ku; Lee, Jun; Cha, Jae Kwan; Kim, Dae Hyun; Kim, Dong Eog; Kim, Joon Tae; Choi, Jay Chol; Yu, Kyung Ho; Lee, Byung Chul; Lee, Ji Sung; Lee, Juneyoung; Gorelick, Philip B.; Bae, Hee Joon.

In: Annals of Neurology, Vol. 79, No. 4, 01.04.2016, p. 560-568.

Research output: Contribution to journalArticle

Park, JM, Kang, K, Cho, YJ, Hong, KS, Lee, KB, Park, TH, Lee, SJ, Ko, Y, Han, MK, Lee, J, Cha, JK, Kim, DH, Kim, DE, Kim, JT, Choi, JC, Yu, KH, Lee, BC, Lee, JS, Lee, J, Gorelick, PB & Bae, HJ 2016, 'Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome', Annals of Neurology, vol. 79, no. 4, pp. 560-568. https://doi.org/10.1002/ana.24602
Park JM, Kang K, Cho YJ, Hong KS, Lee KB, Park TH et al. Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome. Annals of Neurology. 2016 Apr 1;79(4):560-568. https://doi.org/10.1002/ana.24602
Park, Jong Moo ; Kang, Kyusik ; Cho, Yong Jin ; Hong, Keun Sik ; Lee, Kyung Bok ; Park, Tai Hwan ; Lee, Soo Joo ; Ko, Youngchai ; Han, Moon Ku ; Lee, Jun ; Cha, Jae Kwan ; Kim, Dae Hyun ; Kim, Dong Eog ; Kim, Joon Tae ; Choi, Jay Chol ; Yu, Kyung Ho ; Lee, Byung Chul ; Lee, Ji Sung ; Lee, Juneyoung ; Gorelick, Philip B. ; Bae, Hee Joon. / Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome. In: Annals of Neurology. 2016 ; Vol. 79, No. 4. pp. 560-568.
@article{868d1b83e6274da7882158d6c5ba539c,
title = "Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome",
abstract = "Objective The effect of prestroke aspirin use on initial severity, hemorrhagic transformation, and functional outcome of ischemic stroke is uncertain. Methods Using a multicenter stroke registry database, patients with acute ischemic stroke of three subtypes (large artery atherosclerosis [LAA], small vessel occlusion [SVO], or cardioembolism [CE]) were identified. NIH stroke scale (NIHSS) and hemorrhagic transformation at presentation and discharge modified Rankin Scale (mRS) were compared between prestroke aspirin users and nonusers. Results Among the 10,433 patients, 1,914 (18.3{\%}) reported prestroke aspirin use. On crude analysis, initial NIHSS scores of aspirin users were higher than nonusers (mean difference: 0.35; 95{\%} confidence interval [CI]: 0.04-0.66). However, a multivariable analysis with an application of inverse probability of treatment weighting based on a propensity score of prestroke aspirin, having an interaction effect of prestroke aspirin use and stroke subtype in the model, showed less stroke severity for aspirin users in LAA, but not in SVO and CE than for nonusers; mean difference in NIHSS scores in LAA was -0.97 (95{\%} CI: -1.45 to -0.49). With respect to hemorrhagic transformation and mRS, no significant interaction effects were found. Prestroke aspirin use increased the risk of hemorrhagic transformation (adjusted odd ratio: 1.34; 95{\%} CI: 1.05-1.73), but decreased the odds of the higher discharge mRS (0.86; 0.76-0.96). Interpretation Prestroke aspirin use may reduce initial stroke severity in atherothrombotic stroke and can improve functional outcome at discharge despite an increase of hemorrhagic transformation irrespective of stroke subtype.",
author = "Park, {Jong Moo} and Kyusik Kang and Cho, {Yong Jin} and Hong, {Keun Sik} and Lee, {Kyung Bok} and Park, {Tai Hwan} and Lee, {Soo Joo} and Youngchai Ko and Han, {Moon Ku} and Jun Lee and Cha, {Jae Kwan} and Kim, {Dae Hyun} and Kim, {Dong Eog} and Kim, {Joon Tae} and Choi, {Jay Chol} and Yu, {Kyung Ho} and Lee, {Byung Chul} and Lee, {Ji Sung} and Juneyoung Lee and Gorelick, {Philip B.} and Bae, {Hee Joon}",
year = "2016",
month = "4",
day = "1",
doi = "10.1002/ana.24602",
language = "English",
volume = "79",
pages = "560--568",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome

AU - Park, Jong Moo

AU - Kang, Kyusik

AU - Cho, Yong Jin

AU - Hong, Keun Sik

AU - Lee, Kyung Bok

AU - Park, Tai Hwan

AU - Lee, Soo Joo

AU - Ko, Youngchai

AU - Han, Moon Ku

AU - Lee, Jun

AU - Cha, Jae Kwan

AU - Kim, Dae Hyun

AU - Kim, Dong Eog

AU - Kim, Joon Tae

AU - Choi, Jay Chol

AU - Yu, Kyung Ho

AU - Lee, Byung Chul

AU - Lee, Ji Sung

AU - Lee, Juneyoung

AU - Gorelick, Philip B.

AU - Bae, Hee Joon

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Objective The effect of prestroke aspirin use on initial severity, hemorrhagic transformation, and functional outcome of ischemic stroke is uncertain. Methods Using a multicenter stroke registry database, patients with acute ischemic stroke of three subtypes (large artery atherosclerosis [LAA], small vessel occlusion [SVO], or cardioembolism [CE]) were identified. NIH stroke scale (NIHSS) and hemorrhagic transformation at presentation and discharge modified Rankin Scale (mRS) were compared between prestroke aspirin users and nonusers. Results Among the 10,433 patients, 1,914 (18.3%) reported prestroke aspirin use. On crude analysis, initial NIHSS scores of aspirin users were higher than nonusers (mean difference: 0.35; 95% confidence interval [CI]: 0.04-0.66). However, a multivariable analysis with an application of inverse probability of treatment weighting based on a propensity score of prestroke aspirin, having an interaction effect of prestroke aspirin use and stroke subtype in the model, showed less stroke severity for aspirin users in LAA, but not in SVO and CE than for nonusers; mean difference in NIHSS scores in LAA was -0.97 (95% CI: -1.45 to -0.49). With respect to hemorrhagic transformation and mRS, no significant interaction effects were found. Prestroke aspirin use increased the risk of hemorrhagic transformation (adjusted odd ratio: 1.34; 95% CI: 1.05-1.73), but decreased the odds of the higher discharge mRS (0.86; 0.76-0.96). Interpretation Prestroke aspirin use may reduce initial stroke severity in atherothrombotic stroke and can improve functional outcome at discharge despite an increase of hemorrhagic transformation irrespective of stroke subtype.

AB - Objective The effect of prestroke aspirin use on initial severity, hemorrhagic transformation, and functional outcome of ischemic stroke is uncertain. Methods Using a multicenter stroke registry database, patients with acute ischemic stroke of three subtypes (large artery atherosclerosis [LAA], small vessel occlusion [SVO], or cardioembolism [CE]) were identified. NIH stroke scale (NIHSS) and hemorrhagic transformation at presentation and discharge modified Rankin Scale (mRS) were compared between prestroke aspirin users and nonusers. Results Among the 10,433 patients, 1,914 (18.3%) reported prestroke aspirin use. On crude analysis, initial NIHSS scores of aspirin users were higher than nonusers (mean difference: 0.35; 95% confidence interval [CI]: 0.04-0.66). However, a multivariable analysis with an application of inverse probability of treatment weighting based on a propensity score of prestroke aspirin, having an interaction effect of prestroke aspirin use and stroke subtype in the model, showed less stroke severity for aspirin users in LAA, but not in SVO and CE than for nonusers; mean difference in NIHSS scores in LAA was -0.97 (95% CI: -1.45 to -0.49). With respect to hemorrhagic transformation and mRS, no significant interaction effects were found. Prestroke aspirin use increased the risk of hemorrhagic transformation (adjusted odd ratio: 1.34; 95% CI: 1.05-1.73), but decreased the odds of the higher discharge mRS (0.86; 0.76-0.96). Interpretation Prestroke aspirin use may reduce initial stroke severity in atherothrombotic stroke and can improve functional outcome at discharge despite an increase of hemorrhagic transformation irrespective of stroke subtype.

UR - http://www.scopus.com/inward/record.url?scp=84975698143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975698143&partnerID=8YFLogxK

U2 - 10.1002/ana.24602

DO - 10.1002/ana.24602

M3 - Article

C2 - 26754410

AN - SCOPUS:84975698143

VL - 79

SP - 560

EP - 568

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 4

ER -